search
Back to results

Electromagnetic Therapy for Autism Spectrum Disorder

Primary Purpose

Autism Spectrum Disorder

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Electromagnetic therapy
Sponsored by
The University of Hong Kong
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Autism Spectrum Disorder focused on measuring Autism spectrum disorder, ASD, EMT, Electromagnetic therapy, Chinese Medicine

Eligibility Criteria

3 Years - 12 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: aged 3-12 years; have had a principal diagnosis of ASD according to the diagnostic criteria for ASD in the DSM-5; The score of CARS is 30-37 (mild to moderate ASD) at entry; and his/her parents or legal guardian give a written informed consent that indicates the permission to participate in the study. Exclusion Criteria: Children suffer a significant comorbid congenital disease or brain injury, such as Down syndrome, mental retardation, and cerebral palsy; Children have been suffering uncontrolled epilepsy or seizure; Children have heart diseases; Children have participated in other investigational studies in previous 3 months; Children have pediatric massage or acupuncture in previous 2 months; or they have severe skin lesions or scar on the areas the treatment will be performed.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    CAU+EMT groups

    CAU Group

    Arm Description

    CAU+EMT group will continue their current interventions and medications as usual. The existing interventions and medications will be recorded and serve as covariates included in outcome analysis. Besides, CAU+EMT group will receive a total of 30 sessions of EMT within 12 weeks (2 - 3 sessions/week).

    CAU group will continue their current interventions and medications as usual. The existing interventions and medications will be recorded and serve as covariates included in outcome analysis.Those who are initially assigned to CAU group will receive EMT for 12 weeks after they complete the trial. The post-trial treatment will serve as a compensation for their participation.

    Outcomes

    Primary Outcome Measures

    Childhood Autism Rating Scale(CARS)
    CARS consists of 15 items that cover all domains of ASD symptoms: 1, relationship to people; 2, Imitation; 3, emotional response; 4, body use; 5, object use; 6, adaptation to change; 7, visual response; 8, listening response; 9, taste-smell-touch response and use; 10, fear and nervousness; 11, verbal communication; 12. non-verbal communication; 13. Activity level; 14. Level and consistency of intellectual response; 15, general impressions. Each item is scored from "1" (normal behavior) to "4" (severely abnormal behavior), with a total score ranging from 15 to 60. Scores 30-37 indicate mild to moderate ASD; 38-60 indicate severe.

    Secondary Outcome Measures

    Autism Treatment Evaluation Scale (ATEC)
    Autism Treatment Evaluation Scale is evaluated by a parent and serve as supplementary to CARS.The minimum vale of ATEC is 0 and the maximum value is 197, the higher the score the worse the outcome.
    Children's Sleep Habits Questionnaire (CSHQ)
    The minimum vale of CSHQ is 0 and the maximum value is 66, the higher the score the worse the outcome.
    Clinical Global Impression-Severity (CGI-S)
    The minimum vale of CGI-S is 0 and the maximum value is 7, the higher the score the worse the outcome.
    Clinical Global Impression Severity-Improvement (CGI-I)
    The minimum vale of CGI-I is 0 and the maximum value is 7, the higher the score the worse the outcome.

    Full Information

    First Posted
    July 6, 2023
    Last Updated
    October 13, 2023
    Sponsor
    The University of Hong Kong
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT06085287
    Brief Title
    Electromagnetic Therapy for Autism Spectrum Disorder
    Official Title
    Electromagnetic Therapy for Autism Spectrum Disorder: a Pilot Randomized Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    November 1, 2023 (Anticipated)
    Primary Completion Date
    June 1, 2025 (Anticipated)
    Study Completion Date
    December 31, 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    The University of Hong Kong

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The investigators hypothesize that electromagnetic therapy (EMT) could produce greater improvement on Autism spectrum disorder (ASD) compared to the waitlist control. To test this hypothesis, a pilot randomized waitlist-controlled trial is designed to achieve the 2 aims: To evaluate the efficacy of EMT in improving children with ASD as measured by Childhood Autism Rating Scale (CARS) by comparing the change in CARS scores from baseline to week 12 between the two groups. To assess the safety of EMT by comparing the number of participants with adverse events, number of participants withdrawn and reasons of withdrawal in treatment group with those in the control group. A pilot randomized waitlist-controlled trial is designed. A total of 30 children aged 3-12 years with a principal diagnosis of ASD will be recruited. They will be randomly assigned to Care-As Usual (CAU) and CAU+EMT groups (n = 15 each group). Participants on the CAU+EMT group will receive a total of 30 sessions of EMT within 12 weeks (2 - 3 sessions/week).Those who are initially assigned to CAU group will receive EMT for 12 weeks after they complete the trial. The post-trial treatment will serve as a compensation for their participation.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Autism Spectrum Disorder
    Keywords
    Autism spectrum disorder, ASD, EMT, Electromagnetic therapy, Chinese Medicine

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    30 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    CAU+EMT groups
    Arm Type
    Experimental
    Arm Description
    CAU+EMT group will continue their current interventions and medications as usual. The existing interventions and medications will be recorded and serve as covariates included in outcome analysis. Besides, CAU+EMT group will receive a total of 30 sessions of EMT within 12 weeks (2 - 3 sessions/week).
    Arm Title
    CAU Group
    Arm Type
    No Intervention
    Arm Description
    CAU group will continue their current interventions and medications as usual. The existing interventions and medications will be recorded and serve as covariates included in outcome analysis.Those who are initially assigned to CAU group will receive EMT for 12 weeks after they complete the trial. The post-trial treatment will serve as a compensation for their participation.
    Intervention Type
    Device
    Intervention Name(s)
    Electromagnetic therapy
    Intervention Description
    Electromagnetic therapy will be performed using an electromagnetic stimulator (Smart Cap). Chinese medicine practitioners who have at least 3 years of experience will conduct EMT after training. Each session of EMT will take 20-25 min, with 2-3 sessions per week, total of 30 sessions finished within 12 weeks.
    Primary Outcome Measure Information:
    Title
    Childhood Autism Rating Scale(CARS)
    Description
    CARS consists of 15 items that cover all domains of ASD symptoms: 1, relationship to people; 2, Imitation; 3, emotional response; 4, body use; 5, object use; 6, adaptation to change; 7, visual response; 8, listening response; 9, taste-smell-touch response and use; 10, fear and nervousness; 11, verbal communication; 12. non-verbal communication; 13. Activity level; 14. Level and consistency of intellectual response; 15, general impressions. Each item is scored from "1" (normal behavior) to "4" (severely abnormal behavior), with a total score ranging from 15 to 60. Scores 30-37 indicate mild to moderate ASD; 38-60 indicate severe.
    Time Frame
    The changes from baseline to week 12, week 24 and week 36.
    Secondary Outcome Measure Information:
    Title
    Autism Treatment Evaluation Scale (ATEC)
    Description
    Autism Treatment Evaluation Scale is evaluated by a parent and serve as supplementary to CARS.The minimum vale of ATEC is 0 and the maximum value is 197, the higher the score the worse the outcome.
    Time Frame
    The changes from baseline, week 12, week 24 and week 36.
    Title
    Children's Sleep Habits Questionnaire (CSHQ)
    Description
    The minimum vale of CSHQ is 0 and the maximum value is 66, the higher the score the worse the outcome.
    Time Frame
    The changes from baseline, week 12, week 24 and week 36.
    Title
    Clinical Global Impression-Severity (CGI-S)
    Description
    The minimum vale of CGI-S is 0 and the maximum value is 7, the higher the score the worse the outcome.
    Time Frame
    The changes from baseline, week 12, week 24 and week 36.
    Title
    Clinical Global Impression Severity-Improvement (CGI-I)
    Description
    The minimum vale of CGI-I is 0 and the maximum value is 7, the higher the score the worse the outcome.
    Time Frame
    The changes from baseline, week 12, week 24 and week 36.

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    3 Years
    Maximum Age & Unit of Time
    12 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: aged 3-12 years; have had a principal diagnosis of ASD according to the diagnostic criteria for ASD in the DSM-5; The score of CARS is 30-37 (mild to moderate ASD) at entry; and his/her parents or legal guardian give a written informed consent that indicates the permission to participate in the study. Exclusion Criteria: Children suffer a significant comorbid congenital disease or brain injury, such as Down syndrome, mental retardation, and cerebral palsy; Children have been suffering uncontrolled epilepsy or seizure; Children have heart diseases; Children have participated in other investigational studies in previous 3 months; Children have pediatric massage or acupuncture in previous 2 months; or they have severe skin lesions or scar on the areas the treatment will be performed.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Kwai Ching Lo, PHD
    Phone
    (852) 3917 6462
    Email
    angelos@hku.hk
    First Name & Middle Initial & Last Name or Official Title & Degree
    Zhang Jin Zhang, PHD
    Phone
    (852) 3917 6445
    Email
    zhangzj@hku.hk
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Kwai Ching Lo, PHD
    Organizational Affiliation
    The University of Hong Kong
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes

    Learn more about this trial

    Electromagnetic Therapy for Autism Spectrum Disorder

    We'll reach out to this number within 24 hrs